PERCEPTIVE ADVISORS LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in Endo Pharmaceuticals Solutions Inc. ($IDEV) and 10% Owner in REPROS THERAPEUTICS INC. ($RPRX) and 10% Owner in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in PENWEST PHARMACEUTICALS CO ($PPCO) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in Aegerion Pharmaceuticals, Inc. ($AEGR) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX).
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, AEGR, FOLD, IDEV, PPCO, RPRX, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 2,100,000 | 13,650,000 | 14,439,444 | 12.3 M to 14.4 M (+17.02 %) |
| Jul 01 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 530,000 | 1,855,000 | 12,339,444 | 11.8 M to 12.3 M (+4.49 %) |
| Jul 01 2014 | FOLD | AMICUS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 3,470,000 | 12,145,000 | 11,809,444 | 8.3 M to 11.8 M (+41.61 %) |
| Nov 06 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.84 | 3,250 | 22,220 | 6,374,060 | 6.4 M to 6.4 M (+0.05 %) |
| Nov 06 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.84 | 46,750 | 319,630 | 6,370,810 | 6.3 M to 6.4 M (+0.74 %) |
| Nov 06 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.88 | 6,825 | 46,959 | 6,324,060 | 6.3 M to 6.3 M (+0.11 %) |
| Nov 06 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.88 | 98,175 | 675,483 | 6,317,235 | 6.2 M to 6.3 M (+1.58 %) |
| Nov 12 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 6,500 | 42,238 | 6,574,060 | 6.6 M to 6.6 M (+0.10 %) |
| Nov 12 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.50 | 93,500 | 607,572 | 6,567,560 | 6.5 M to 6.6 M (+1.44 %) |
| Nov 12 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.52 | 6,500 | 42,358 | 6,474,060 | 6.5 M to 6.5 M (+0.10 %) |
| Nov 12 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.52 | 93,500 | 609,302 | 6,467,560 | 6.4 M to 6.5 M (+1.47 %) |
| Nov 04 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.17 | 150,218 | 1,077,033 | 6,219,060 | 6.1 M to 6.2 M (+2.48 %) |
| Nov 04 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.17 | 10,442 | 74,867 | 6,068,842 | 6.1 M to 6.1 M (+0.17 %) |
| Nov 04 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.69 | 8,000 | 53,546 | 6,058,400 | 6.1 M to 6.1 M (+0.13 %) |
| Nov 04 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.69 | 192,000 | 1,285,094 | 6,050,400 | 5.9 M to 6.1 M (+3.28 %) |
| Jul 24 2013 | ACRX | ACELRX PHARMACEUTI ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.65 | 850,000 | 9,902,500 | 5,858,400 | 5 M to 5.9 M (+16.97 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 22.71 | 30,000 | 681,300 | 2,595,293 | 2.6 M to 2.6 M (+1.17 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 21.76 | 70,000 | 1,523,200 | 2,565,293 | 2.5 M to 2.6 M (+2.81 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 20.75 | 20,000 | 415,000 | 2,495,293 | 2.5 M to 2.5 M (+0.81 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 21.01 | 20,000 | 420,200 | 2,475,293 | 2.5 M to 2.5 M (+0.81 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 19.50 | 10,000 | 195,000 | 2,455,293 | 2.4 M to 2.5 M (+0.41 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 21.12 | 30,000 | 633,600 | 2,445,293 | 2.4 M to 2.4 M (+1.24 %) |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | X | 17.50 | 2,475 | 43,313 | 0 | |
| Dec 03 2012 | AEGR | Aegerion Pharmaceu ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | X | 17.50 | 247,500 | 4,331,250 | 2,347,233 | 2.6 M to 2.3 M (-9.54 %) |
| May 15 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.38 | 59,500 | 439,283 | 2,862,560 | 2.8 M to 2.9 M (+2.12 %) |
| May 14 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.35 | 25,000 | 158,800 | 2,803,060 | 2.8 M to 2.8 M (+0.90 %) |
| May 14 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.35 | 145,000 | 921,040 | 2,778,060 | 2.6 M to 2.8 M (+5.51 %) |
| May 11 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.82 | 15,000 | 72,300 | 2,633,060 | 2.6 M to 2.6 M (+0.57 %) |
| May 11 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.82 | 310,000 | 1,493,797 | 2,618,060 | 2.3 M to 2.6 M (+13.43 %) |
| Nov 09 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 2,340,000 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
| Aug 24 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 2.01 | 6,600 | 13,266 | 2,333,400 | 2.3 M to 2.3 M (-0.28 %) |
| Aug 24 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 2.11 | 1,500 | 3,165 | 2,340,000 | 2.3 M to 2.3 M (-0.06 %) |
| Aug 10 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.18 | 10,000 | 21,800 | 0 | -10,000 to 0 (-100.00 %) |
| Aug 05 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.23 | 30,000 | 66,900 | 0 | -30,000 to 0 (-100.00 %) |
| Aug 05 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.25 | 10,000 | 22,500 | 0 | -10,000 to 0 (-100.00 %) |
| Aug 05 2011 | GEVA | SYNAGEVA BIOPHARMA ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.19 | 30,000 | 65,700 | 0 | -30,000 to 0 (-100.00 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 30,300 | 227,250 | 2,308,060 | 2.3 M to 2.3 M (+1.33 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 200,000 | 1,000,000 | 2,277,760 | 2.1 M to 2.3 M (+9.63 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 95,300 | 714,750 | 2,077,760 | 2 M to 2.1 M (+4.81 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 400,000 | 2,000,000 | 1,982,460 | 1.6 M to 2 M (+25.28 %) |
| Aug 17 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 800 | 6,000 | 1,582,460 | 1.6 M to 1.6 M (+0.05 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 3,800 | 28,500 | 1,581,660 | 1.6 M to 1.6 M (+0.24 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 100 | 750 | 1,577,860 | 1.6 M to 1.6 M (+0.01 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 4,600 | 34,500 | 1,577,760 | 1.6 M to 1.6 M (+0.29 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 15,100 | 113,250 | 1,573,160 | 1.6 M to 1.6 M (+0.97 %) |
| Mar 18 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.22 | 60,000 | 313,200 | 1,558,060 | 1.5 M to 1.6 M (+4.01 %) |
| Mar 18 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.19 | 26,500 | 137,535 | 1,498,060 | 1.5 M to 1.5 M (+1.80 %) |
| Mar 09 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 30,000 | 194,100 | 1,471,560 | 1.4 M to 1.5 M (+2.08 %) |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.62 | 20,000 | 92,400 | 1,441,560 | 1.4 M to 1.4 M (+1.41 %) |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.62 | 30,000 | 138,600 | 1,421,560 | 1.4 M to 1.4 M (+2.16 %) |
| Mar 01 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.46 | 88,273 | 393,698 | 1,391,560 | 1.3 M to 1.4 M (+6.77 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.49 | 10,000 | 44,900 | 1,303,287 | 1.3 M to 1.3 M (+0.77 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.49 | 38,922 | 174,760 | 1,293,287 | 1.3 M to 1.3 M (+3.10 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.36 | 110,000 | 479,600 | 1,254,365 | 1.1 M to 1.3 M (+9.61 %) |
| Mar 31 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 3.62 | 925,000 | 3,348,500 | 925,000 | |
| Mar 09 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 1.26 | 274,362 | 345,696 | 6,476,446 | 6.8 M to 6.5 M (-4.06 %) |
| Mar 03 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 1.75 | 2,300 | 4,025 | 6,750,808 | 6.8 M to 6.8 M (-0.03 %) |
| Jan 28 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 23,900 | 119,500 | 6,753,108 | 6.7 M to 6.8 M (+0.36 %) |
| Jan 12 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 25,000 | 125,000 | 6,729,208 | 6.7 M to 6.7 M (+0.37 %) |
| Jan 12 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 2,300 | 11,500 | 6,704,208 | 6.7 M to 6.7 M (+0.03 %) |
| Jan 06 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 4,700 | 23,500 | 6,701,908 | 6.7 M to 6.7 M (+0.07 %) |
| Jan 06 2009 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | J | 1.26 | 274,362 | 345,696 | 6,697,208 | 6.4 M to 6.7 M (+4.27 %) |
| Mar 09 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | U | 4.50 | 2,221,248 | 9,995,616 | 7,891,067 | 10.1 M to 7.9 M (-21.97 %) |
| Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.49 | 25,000 | 137,125 | 10,112,315 | 10.1 M to 10.1 M (+0.25 %) |
| Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.49 | 225,000 | 1,234,125 | 10,087,315 | 9.9 M to 10.1 M (+2.28 %) |
| Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.55 | 7,500 | 41,634 | 9,862,315 | 9.9 M to 9.9 M (+0.08 %) |
| Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.55 | 675,000 | 3,747,060 | 9,787,315 | 9.1 M to 9.8 M (+7.41 %) |
| Jul 17 2008 | PPCO | PENWEST PHARMACEUT ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 91,500 | 457,500 | 6,387,546 | 6.3 M to 6.4 M (+1.45 %) |
Page: 1